ClinicalTrials.Veeva

Menu

The Effect of Pharmacological Treatment for ADHD on Physical Performance in Male Adolescents

L

Loewenstein Hospital

Status

Enrolling

Conditions

ADHD

Treatments

Other: Motor performance tests

Study type

Observational

Funder types

Other

Identifiers

NCT05517785
0003-22-LOE

Details and patient eligibility

About

The aim of this study is to evaluate the effects of stimulant ADHD pharmacotherapy on motor performance in male adolescents.

Full description

This study is designed as a single-center, crossover, randomized study. 70 high-school aged males aged between 15 and 18 years with a diagnosis of ADHD who are being treated pharmacologically using stimulants (such as Ritalin, Concerta, Vyvanse etc) will be recruited. The study will investigate motor performance using several motor function tests both with and without the influence of stimulant ADHD medications.

Participants will be assessed on two separate occasions, both sessions will occur during the morning in their regular school environment. During the sessions, participants will be randomized, 50% will be assessed one hour after taking their usual stimulant ADHD medication and the other 50% will be asked to postpone taking their usual stimulant ADHD medication until the session is finished. During the two separate sessions, all participants will be asked to perform the following motor tests: plank, single leg stance test, standing long jump test (broad jump), 4 x 10 agility tests and 20 m shuttle run tests (beeps).

Enrollment

70 estimated patients

Sex

Male

Ages

15 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • High school male students
  • Diagnosis of ADHD
  • Treatment with prescribed stimulants for ADHD (e.g. Concerta, Ritalin, Phenidin, Focalin etc.).

Exclusion criteria

  • Students with concomitant chronic disease (including asthma, cardiac, motor, neurological and gastrointestinal disturbances)
  • History of acute illness in the previous two weeks
  • Any injuries that would inhibit the ability to exercise or play sport
  • Students unable to obtain parental/guardian consent
  • Students unwilling to participate

Trial design

70 participants in 2 patient groups

Medicated
Description:
Assessment of motor function will be performed 1 hour after taking the usual stimulant ADHD medication.
Treatment:
Other: Motor performance tests
Unmedicated
Description:
Participants will remain unmedicated for the duration of the assessment, and will delay taking their usual stimulant ADHD medication until all the motor function assessments are completed.
Treatment:
Other: Motor performance tests

Trial contacts and locations

1

Loading...

Central trial contact

Sharon Tsuk, Ph.D; Aviva Mimouni-Bloch, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems